Related Experiment Video
Updated: Mar 22, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier
S F Swedan1, W A Hayajneh, G N Bshara
1Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
Insights
A high percentage of young children carry drug-resistant Streptococcus pneumoniae, with macrolide resistance prevalent. This highlights the urgent need to address antimicrobial resistance in pediatric populations.
Area of Science:
- Microbiology
- Pediatrics
- Infectious Diseases
Background:
- Streptococcus pneumoniae is a common cause of childhood infections and is increasingly resistant to antibiotics.
- Understanding carriage rates, serotypes, and resistance mechanisms is crucial for public health.
Purpose of the Study:
- To investigate Streptococcus pneumoniae carriage in children under 5.
- To identify prevalent serotypes and antimicrobial resistance patterns, particularly to macrolides.
- To determine the genetic basis of macrolide resistance.
Main Methods:
- Collected nasopharyngeal swabs from 157 children under 5.
- Performed cultural isolation and antimicrobial susceptibility testing (disk diffusion, E-test).
- Identified serotypes and macrolide resistance genes (erm(B), mef(E)) using multiplex PCR.
Main Results:
- S. pneumoniae was carried by 33.8% of children, with higher rates in males.
- Prevalent serotypes included 19F, 6A/B, 11A, 19A, 14, and 15B/C.
- Macrolide resistance was 60.4%, often coexisting with resistance to other antibiotics. erm(B) and mef(E) genes were identified in resistant isolates.
Conclusions:
- A significant proportion of children carry multidrug-resistant S. pneumoniae.
- The study identifies key serotypes and resistance genes contributing to antimicrobial resistance in children.
- Findings underscore the public health challenge posed by resistant S. pneumoniae in pediatric populations.
Aims:
Streptococcus pneumoniae, an opportunistic pathogen commonly carried asymptomatically in the nasopharynx of children, is associated with increasing rates of treatment failures due to a worldwide increase in drug resistance. We investigated the carriage of S. pneumoniae in children 5 years or younger, the identity of prevalent serotypes, the rates of resistance to macrolides and other antimicrobial agents and the genotypes responsible for macrolide resistance.
Materials And Methods:
Nasopharyngeal swabs were collected from 157 children under 5 years for cultural isolation of S. pneumoniae. Antibiogram of isolates was determined using the disk diffusion test, and the minimal inhibitory concentration to macrolides was determined using the E-test. Isolate serotypes and macrolide resistance genes, erm(B) and mef(E), were identified using multiplex polymerase chain reactions.
Results:
S. pneumoniae was recovered from 33.8% of children; 41.9% among males and 21.9% among females (P = 0.009). The highest carriage rate occurred among age groups 7-12 months and 49-60 months. Most frequent serotypes were 19F, 6A/B, 11A, 19A, 14 and 15B/C. Resistance to macrolides was 60.4%. Resistance to oxacillin, trimethoprim/sulfamethoxazole and clindamycin was present among 90.6%, 54.7% and 32.1% of isolates, respectively. All isolates were susceptible to chloramphenicol, levofloxacin and vancomycin. Isolates resistant to one or more macrolide drugs were more likely to be multidrug resistant. Resistance to clindamycin or oxacillin coexisted with macrolide resistance. Among the erythromycin-resistant isolates, erm(B), mef(E) and erm(B) and mef(E) genes were present at rates of 43.8%, 37.5% and 6.3%, respectively. Erm(B) and mef(E) were associated with very high level and moderate-to-high level resistance to macrolides, respectively.
Conclusion:
A significant proportion of children harboured macrolide and multidrug-resistant S. pneumoniae.
Related Concept Videos
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

